Lovastatin

CHEMBL503 Phase 4 Aprobado Small molecule
Half-Life
2-3 hours
Bioavailability
Protein Binding
Molecular Weight
404.5 g/mol
LogP
4.3
Phase
4

A naturally occurring statin originally derived from fungus, used to lower LDL cholesterol and reduce the risk of cardiovascular events, and studied for potential anticancer and neuroprotective effects. It inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis.

Peso molecular

404,5390 g/mol

LogP

4,30

TPSA

72,80 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Clases de fármacos

Mecanismo de acción

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Pharmacokinetics (PK)

Half-Life 2-3 hours

Pharmacodynamics (PD)

Mecanismo

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21

InChI

InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1

Molecular Formula

C24H36O5

HBD / HBA

1 / 5

Enlaces Rotables

7

Átomos Pesados

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A naturally occurring statin originally derived from fungus, used to lower LDL cholesterol and reduce the risk of cardiovascular events, and studied for potential anticancer and neuroprotective effects. It inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis.

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Key pharmacokinetic parameters for Lovastatin: Half-life: 2-3 hours.

Yes, Lovastatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL503. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 53232. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.